Royal Philips: Philips and Ibex Medical Analytics team to accelerate adoption of AI-powered digital pathology Philips and Ibex Medical Analytics cooperate to globally commercialize clinically proven, AI-powered digital pathology solutions Combination of Philips' digital pathology solutions and Ibex's AI-powered Galen platform has improved reporting efficiency by 27%, driven 37% productivity gains, and improved consistency and accuracy to enhance diagnostic confidence Collaboration furthers Philips' commitment to integrated diagnostics providing a clear path to precision diagnosis Amsterdam, The Netherlands and Tel Aviv, Israel - Royal Philips, a pioneer in artificial intelligence) and Ibex's Galen AI-powered cancer diagnostics platform [1], currently in clinical use in Europe and the Middle East, empowers pathologists to generate objective, reproducible results, increase diagnostic confidence, and enable the productivity and efficiency improvements needed to cope with ever-increasing demand for pathology-based diagnostics.